| RS943875725 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS943893227 |
RHOBTB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS943924098 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS943939913 |
LZTR1
|
Health Risk |
Likely pathogenic |
Noonan syndrome 10, Hereditary cancer-predisposing syndrome |
| RS943943635 |
PDE6A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 43, Retinitis pigmentosa 43 |
| RS943952854 |
CHMP1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS943958169 |
GRIN2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS943965548 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS943979644 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS944013929 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS944029472 |
SLC45A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Oculocutaneous albinism type 4, Oculocutaneous albinism type 4 |
| RS944032875 |
RNASEH2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Aicardi-Goutieres syndrome 2, Aicardi-Goutieres syndrome 2 |
| RS944083227 |
FANCC
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group C, Hereditary cancer-predisposing syndrome |
| RS944152647 |
TNNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS944211695 |
SIN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS944235493 |
IRAK4
|
Health Risk |
Likely pathogenic |
Immunodeficiency 67, Invasive pneumococcal disease |
| RS944263459 |
MAT1A
|
Health Risk |
Pathogenic |
Hepatic methionine adenosyltransferase deficiency, Hepatic methionine adenosyltransferase deficiency |
| RS944284466 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS9443200 |
MYO6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 37, Autosomal dominant nonsyndromic hearing loss 22 |
| RS944335096 |
EXOSC3
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1B, Pontocerebellar hypoplasia type 1B |
| RS944343501 |
NEBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS944413465 |
HNF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian cancer, 6 conditions |
| RS944415019 |
ATP7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Menkes kinky-hair syndrome, Cutis laxa |
| RS944418938 |
KIF22
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS944446438 |
DNAH9
|
Health Risk |
Likely pathogenic |
Ciliary dyskinesia, primary |
| RS944452644 |
CYP1B1
|
Health Risk |
Likely pathogenic |
Glaucoma 3A, Anterior segment dysgenesis 6 |
| RS944499155 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly, normal intelligence and immunodeficiency |
| RS944539388 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS944560685 |
PNPLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neutral lipid storage myopathy, PNPLA2-related disorder |
| RS944567230 |
LAMC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS944576125 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS944580031 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS944607375 |
SERPINA1
|
Health Risk |
Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS944608317 |
DNMT3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS944626522 |
FRAS1
|
Health Risk |
Likely pathogenic |
— |
| RS944647296 |
DNAAF4
|
Health Risk |
Likely pathogenic |
— |
| RS944650989 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS944652890 |
ADAMTS13
|
Health Risk |
Conflicting classifications of pathogenicity |
Upshaw-Schulman syndrome, Inborn genetic diseases |
| RS944675223 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS944680171 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, KMT2D-related disorder |
| RS944680882 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 4, Hereditary cancer-predisposing syndrome |
| RS944693159 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Lymphangiomyomatosis |
| RS944696965 |
TOP2B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS944713270 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS944728845 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS944730356 |
GDF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS944736912 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS944778197 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS944804641 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS944843686 |
HAMP
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemochromatosis type 2B, Hereditary hemochromatosis |
| RS944844493 |
SGSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-A |
| RS944860201 |
NIPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 6, Inborn genetic diseases |
| RS9448884 |
BCKDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS944930983 |
FAM111A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS944956263 |
PHIP
|
Health Risk |
Conflicting classifications of pathogenicity |
PHIP-related disorder, PHIP-related disorder |
| RS944999468 |
KBTBD13
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Nemaline myopathy 6 |
| RS945058783 |
EXT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Exostoses, multiple |
| RS945091158 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS945102665 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS945104524 |
PEX12
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS945135468 |
LEPR
|
Health Risk |
Pathogenic |
LEPR-related disorder, LEPR-related disorder |
| RS945136467 |
PRNP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inherited prion disease, Huntington disease-like 1 |
| RS945181516 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS945207649 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schinzel-Giedion syndrome, Intellectual disability |
| RS945234297 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS945252214 |
SLC19A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Megaloblastic anemia, thiamine-responsive |
| RS945278904 |
ATP1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomagnesemia, seizures |
| RS945304215 |
TUBGCP4
|
Health Risk |
Pathogenic |
— |
| RS945343783 |
SURF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leigh syndrome, Mitochondrial complex IV deficiency |
| RS945372017 |
NEU1
|
Health Risk |
Pathogenic |
Sialidosis, Sialidosis |
| RS945447694 |
CCDC88C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hydrocephalus, nonsyndromic |
| RS945470080 |
RAC3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies, Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies |
| RS945481319 |
EEF1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 33 |
| RS945517672 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS945537370 |
COG7
|
Health Risk |
Likely pathogenic |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS945554080 |
FGD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4H, Charcot-Marie-Tooth disease type 4 |
| RS945580226 |
C2
|
Health Risk |
Likely pathogenic |
— |
| RS945600680 |
COL17A1
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS945602962 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS945616168 |
LOXHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS945618655 |
C1QB
|
Health Risk |
Conflicting classifications of pathogenicity |
C1Q deficiency 2, C1Q deficiency 2 |
| RS945627261 |
PRRT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic kinesigenic dyskinesia, Seizures |
| RS945657254 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS945734402 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS945794101 |
CDAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type I |
| RS945794813 |
FBXO7
|
Health Risk |
Pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS945798509 |
TG
|
Health Risk |
Likely pathogenic |
— |
| RS945866627 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS945869656 |
AMER1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS945869943 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS945880747 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS945959591 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS945997134 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS946006593 |
GATAD2B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS946029100 |
SYNGAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 5 |
| RS946083212 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Aortic valve disease 1 |
| RS946085339 |
GIPC3
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 15, Autosomal recessive nonsyndromic hearing loss 15 |
| RS946088822 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS946096806 |
CSF3R
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency, Autosomal recessive severe congenital neutropenia due to CSF3R deficiency |
| RS946108501 |
ADAMTS17
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani 4 syndrome, recessive |